Free Trial

SurgePays (NASDAQ:SURG) Share Price Crosses Above Two Hundred Day Moving Average - Here's Why

SurgePays logo with Computer and Technology background

Key Points

  • SurgePays' stock price surpassed its 200-day moving average of $2.44, reaching a high of $2.50 before closing at $2.49 with a trading volume of 72,049 shares.
  • Analysts have mixed opinions on SurgePays, with Wall Street Zen downgrading the stock from "hold" to "sell", while Ascendiant Capital Markets upgraded the price target from $8.75 to $9.00, maintaining a "buy" rating.
  • SurgePays reported a net loss with earnings per share of ($0.36), falling short of analysts' expectations of ($0.31), along with lower revenue of $11.52 million against the forecast of $16.14 million.
  • MarketBeat previews the top five stocks to own by October 1st.

SurgePays, Inc. (NASDAQ:SURG - Get Free Report) shares crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $2.44 and traded as high as $2.50. SurgePays shares last traded at $2.49, with a volume of 72,049 shares changing hands.

Analyst Ratings Changes

SURG has been the topic of a number of analyst reports. Wall Street Zen upgraded shares of SurgePays from a "sell" rating to a "hold" rating in a research note on Saturday. Ascendiant Capital Markets lifted their price objective on shares of SurgePays from $8.75 to $9.00 and gave the company a "buy" rating in a research note on Monday, June 16th. One investment analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the company presently has an average rating of "Buy" and an average target price of $9.00.

Read Our Latest Stock Analysis on SURG

SurgePays Price Performance

The company has a debt-to-equity ratio of 101.87, a current ratio of 1.11 and a quick ratio of 0.84. The firm has a market cap of $55.16 million, a price-to-earnings ratio of -1.08 and a beta of 0.43. The business's 50-day moving average price is $2.85 and its two-hundred day moving average price is $2.47.

SurgePays (NASDAQ:SURG - Get Free Report) last released its quarterly earnings results on Wednesday, August 13th. The medical equipment provider reported ($0.36) earnings per share for the quarter, missing analysts' consensus estimates of ($0.31) by ($0.05). SurgePays had a negative return on equity of 333.87% and a negative net margin of 133.85%.The company had revenue of $11.52 million for the quarter, compared to analyst estimates of $16.14 million. SurgePays has set its FY 2025 guidance at EPS. On average, research analysts forecast that SurgePays, Inc. will post -1.66 EPS for the current fiscal year.

Institutional Trading of SurgePays

Hedge funds have recently made changes to their positions in the stock. D.A. Davidson & CO. acquired a new stake in shares of SurgePays during the first quarter worth approximately $25,000. Goldman Sachs Group Inc. acquired a new position in SurgePays in the first quarter worth $28,000. Baader Bank Aktiengesellschaft acquired a new position in SurgePays in the first quarter worth $35,000. Jane Street Group LLC acquired a new position in SurgePays in the second quarter worth $42,000. Finally, Ethos Financial Group LLC acquired a new position in SurgePays in the first quarter worth $57,000. Institutional investors and hedge funds own 6.94% of the company's stock.

SurgePays Company Profile

(Get Free Report)

SurgePays, Inc, together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities.

Read More

Should You Invest $1,000 in SurgePays Right Now?

Before you consider SurgePays, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SurgePays wasn't on the list.

While SurgePays currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines